Boston Scientific | BSX - Ebit

Aktienkurs
57.60
Täglich Wechseln
0.45 0.79%
Monatlich
-8.21%
Jährlich
-44.18%
Q2 Prognose
60.74




Ebit Veränderung Datum
Abbott USD 1.85B 684M 2026-03
AtriCure USD 2.49M 2.28M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Baxter International USD 66M 280.2M 2026-03
Becton, Dickinson and Co. USD 663M 163M 2025-12
Boston Scientific USD 1.05B 190M 2026-03
CONMED USD 25.42M 11.21M 2026-03
Cooper Companies USD 212.8M 72.4M 2025-12
Danaher USD 1.34B 158M 2026-03
Dexcom USD 255.3M 67.7M 2026-03
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Illumina USD 239M 17M 2026-03
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.51B 2026-03
Masimo USD 83.9M 200K 2025-12
Medtronic USD 1.74B 40M 2025-12
Merit Medical Systems USD 44.16M 10.04M 2026-03
Stryker USD 1.1B 867M 2026-03
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 36.34M 76.31M 2025-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03